| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/17/2002 | EP1222925A2 Kavalactone as TNF-alpha production inhibitor |
| 07/17/2002 | EP1222921A1 Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1222202A2 Ab5 toxin b subunit mutants with altered chemical conjug ation characteristics |
| 07/17/2002 | EP1222201A2 Peptides which stimulate the immune response and tissue regeneration |
| 07/17/2002 | EP1222195A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222179A1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1221976A1 Low dose ifn-gamma for treatment of disease |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221972A1 Plant lectins as mucosal adjuvants |
| 07/17/2002 | EP1221971A2 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 07/17/2002 | EP1221970A2 Compositions and methods for stimulating an immune response against infectious agents |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221968A2 Method of obtaining cellular immune responses from proteins |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221953A1 Treating sleep disorders using desloratadine |
| 07/17/2002 | EP1221941A1 Powder pharmaceutical formulations |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0876398B1 Induction of immune response against desired determinants |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc |
| 07/17/2002 | EP0766668B1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359371A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 07/17/2002 | CN1359302A Remedies for immunoogical diseases |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1358730A Oligose capable of being used as medicine and its surfated products and preparation process thereof, and medicinal composition having same |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420355 Hydrophilic organic solvent; mixed mono-, di-, and triglyceride or a transesterified and polyethoxylated vegetable oil; a polyoxyethylene-sorbitan-fatty ester surfactant; emulsion preconcentrate for oral administration |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420348 Pectic polysaccharides purified from Angelica gigas nakai and purification method and use as immunostimulating agent thereof |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420176 Composition for delivering DNA into antigen presenting cells |
| 07/16/2002 | US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | CA2171738C Parenteral busulfan for treatment of malignant disease |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053595A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053550A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053288A2 A method for the manufacture of compositions containing low concentrations of salts |
| 07/11/2002 | WO2002053184A2 Uses for polycationic compounds as vaccine adjuvants |
| 07/11/2002 | WO2002053180A2 Immunizing compositions and methods of use |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053170A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 07/11/2002 | WO2002053149A2 Medicament containing a polyamine as an active substance |
| 07/11/2002 | WO2002053142A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002053138A2 Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| 07/11/2002 | WO2002053130A2 Sustained release drug delivery devices with coated drug cores |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002053094A2 Method for detoxifying a carbohydrate containing solution |
| 07/11/2002 | WO2002036605A3 Estrone-derivatives having cytoprotective activity |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002013857A3 A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2001095890B1 Oral pharmaceutical compositions containing terbinafine |
| 07/11/2002 | WO2001090747A3 Modulation of t-cell receptor interactions |